Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
MNKD
Stock Latest News
Ratings
MannKind’s Afrezza: Promising Expansion and Growth Potential with FDA sBLA Acceptance
5d ago
MNKD
Premium
The Fly
MannKind announces U.S. FDA accepted sBLA for Afrezza Inhalation Powder
5d ago
MNKD
Premium
Company Announcements
MannKind Completes Acquisition of scPharma
9d ago
8K
MNKD
Premium
The Fly
MannKind completes acquisition of scPharmaceuticals
11d ago
MNKD
SCPH
Premium
Ratings
Buy Rating for MannKind Supported by Strong Tyvaso Efficacy in IPF Treatment
17d ago
MNKD
Premium
The Fly
MannKind names Dr. Ajay Ahuja as Chief Medical Officer
19d ago
MNKD
Premium
Company Announcements
MannKind Corporation’s Phase 3 Study: A Potential Game-Changer for Nontuberculous Mycobacterial Infections
1M ago
MNKD
Premium
The Fly
MannKind price target raised to $15 from $12 at Oppenheimer
1M ago
MNKD
Premium
Ratings
Positive TETON-2 Study Results Drive Buy Rating and Price Target Increase for MannKind
2M ago
MNKD
Premium
The Fly
MannKind price target raised to $11 from $9 at H.C. Wainwright
2M ago
MNKD
UTHR
Premium
The Fly
Unusually active option classes on open September 2nd
2M ago
AG
KR
Premium
Ratings
MannKind’s Strategic Collaborations and Innovations Drive Buy Rating Amid Promising IPF Treatment Developments
2M ago
MNKD
Premium
The Fly
Marvell downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
2M ago
AHL
SWX
Premium
Company Announcements
MannKind Amends License Agreement with United Therapeutics
2M ago
8K
MNKD
Premium
The Fly
MannKind, United Therapeutics expand collaboration for second inhaled therapy
2M ago
MNKD
UTHR
Premium
The Fly
scPharmaceuticals downgraded to Hold from Buy at Maxim
2M ago
MNKD
SCPH
Premium
The Fly
MannKind price target raised to $8 from $7 at RBC Capital
2M ago
MNKD
SCPH
Premium
The Fly
H.C. Wainwright positive on MannKind deal for scPharmaceuticals
2M ago
MNKD
SCPH
Premium
The Fly
H.C. Wainwrights positive on MannKind deal for scPharmaceuticals
2M ago
MNKD
SCPH
Premium
The Fly
Keurig Dr Pepper buys JDE Peet’s, Thoma Bravo to acquire Verint: Morning Buzz
2M ago
S
KR
Premium
Ratings
MannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value Creation
2M ago
MNKD
Premium
Ratings
MannKind’s Strategic Acquisition and Growth Prospects: A Buy Rating by Yun Zhong
2M ago
MNKD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
